6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract pertains to the procurement of Alendronate Tablets for the Department of Veterans Affairs, managed through the Nac Pharmaceuticals solicitation number 36E79725R0069. The acquisition involves a one-year base period with four optional one-year extensions, aiming to supply specified quantities of 35MG and 70MG tablets in various packaging configurations, including bottles and blister packs, with detailed packaging, labeling, and bar-coding requirements aligned with federal standards. The solicitation emphasizes compliance with FAR clauses, including those related to security, privacy, small business subcontracting, and anti-conflict provisions, with references to the USP-NF for pharmaceutical standards and federal specifications for packaging and labeling. Offerors are required to submit firm-fixed-price proposals, including a 0.5% Cost Recovery Fee, covering all line items across the base and option years, with evaluation based on lowest evaluated price among technically acceptable and responsible offers. The contract mandates strict delivery and inspection protocols, with products inspected and accepted at the Government’s destination, ensuring all pharmaceuticals are FDA-approved and manufactured under current Good Manufacturing Practices. Delivery is structured through the Prime Vendor system, with performance periods defined by an implementation window of up to 60 days post-award and subsequent ordering periods extending up to five years, including options. Proposal submissions must be made electronically via email, including a signed SF-1449, with no page limits specified, and must be received by the deadline of November 13, 2025. The contract incorporates extensive FAR and VAAR clauses covering ethics, security, subcontracting, and reporting requirements, and emphasizes the importance of accurate representations regarding small business status, socioeconomic categories, and compliance certifications. Overall, the contract emphasizes quality, compliance, and cost-effectiveness in supplying pharmaceuticals to support VA healthcare operations.
General Info
Contract Value
$0Place of Performance
IL, USASet-Aside
Awardee
MARLEX PHARMACEUTICALS INCAward Issued Date
Timeline
Organization & Contact Information
Full Description
Page 1 of
Presolicitation Notice
Page 1 of 3 Presolicitation Notice *=Required Field Presolicitation Notice
Page 4 of 4
DESCRIPTION Presolicitation Notice
Presolicitation Notice
Page 3 of 3 Page 1 of 4 Page 1 of 4 Presolicitation Notice *=Required Field Presolicitation Notice
Page 1 of 3 Page 1 of Page 1 of PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0069 for an unrestrictive procurement for Alendronate Tablets for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package is a blister pack, but VA will accept unit of use bottles. Solicitation #36E79725R0069 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 28, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: contact@example.gov. The estimated annual requirements are as follows:
ITEM
DESCRIPTION PACKAGE SIZE (BOTTLES/BLISTER PACKS) TOTAL ESTIMATED ANNUAL USAGE (BOTTLES/BLISTER PACKS) 1 ALENDRONATE 35MG TAB 4 21,300 2 ALENDRONATE 35MG TAB 12 5,354 3 ALENDRONATE 70MG TAB 4 80,074 4 ALENDRONATE 70MG TAB 12 100,609
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
